Park, Jong Woong <br/><br/>
Proteasome inhibitor attenuates skeletal muscle reperfusion injury by blocking the pathway of nuclear factor-kappaB activation.  [electronic resource] 

 -  Plastic and reconstructive surgery  Dec 2007 
 - 1808-1818 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-4242 
<br/><br/><label>Standard No.: </label>10.1097/01.prs.0000287245.17319.57  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Vessels--ultrastructure<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Drug Evaluation, Preclinical<br/>Intercellular Adhesion Molecule-1--biosynthesis<br/>Intracellular Signaling Peptides and Proteins<br/>Laser-Doppler Flowmetry<br/>Male<br/>Mice<br/>Microscopy, Video<br/>Muscle, Skeletal--blood supply<br/>NF-kappa B p50 Subunit--antagonists & inhibitors<br/>Nitric Oxide Synthase Type II--biosynthesis<br/>Protease Inhibitors--pharmacology<br/>Proteasome Inhibitors<br/>Proteins--genetics<br/>Pyrazines--pharmacology<br/>Random Allocation<br/>Reperfusion Injury--drug therapy<br/>Surgical Flaps--blood supply<br/>Tyrosine--analogs & derivatives